|
|
|
|
|
|
Found 35 studies with search of: | "Beclomethasone" |
Hide studies that are not seeking new volunteers.
|
|
1 | Completed | Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms | ||||
Condition: | Bronchial Asthma | |||||
Interventions: | Drug: Beclomethasone dipropionate; Drug: Beclomethasone dipropionate/Salbutamol combination; Drug: Salbutamol | |||||
2 | Completed | Rosiglitazone Versus Theophylline in Asthmatic Smokers | ||||
Condition: | Asthma | |||||
Interventions: | Drug: rosiglitazone; Drug: theophylline; Drug: beclomethasone; Drug: inhaled beclomethasone and oral theophylline | |||||
3 | Completed | As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma | ||||
Condition: | Asthma | |||||
Interventions: | Drug: beclomethasone/salbutamol combination; Drug: beclomethasone; Drug: salbutamol | |||||
4 | Recruiting | Childhood Asthma Research and Education (CARE) Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA) | ||||
Condition: | Asthma | |||||
Interventions: | Drug: Beclomethasone dipropionate; Drug: Beclomethasone dipropionate; Drug: Albuterol sulfate | |||||
5 | Completed | Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®) | ||||
Condition: | Bronchial Asthma | |||||
Interventions: | Drug: beclomethasone dipropionate plus formoterol fumarate combination; Drug: budesonide plus formoterol combination | |||||
6 | Terminated | The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease | ||||
Condition: | COPD | |||||
Intervention: | Drug: HFA-134A Beclomethasone DIpropionate (QVAR) | |||||
7 | Recruiting | Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma | ||||
Condition: | Asthma | |||||
Interventions: | Drug: Beclomethasone plus formoterol fixed combination; Drug: Fluticasone plus salmeterol fixed combination | |||||
8 | Completed | EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI | ||||
Condition: | Bronchial Asthma | |||||
Interventions: | Drug: beclomethasone dipropionate plus formoterol fumarate combination; Drug: fluticasone propionate plus salmeterol xinafoate combination | |||||
9 | Completed | Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD | ||||
Conditions: | Graft Vs Host Disease; Gastrointestinal Graft-Versus-Host Disease | |||||
Intervention: | Drug: Oral beclomethasone dipropionate (drug) | |||||
10 | Completed | The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry | ||||
Condition: | Asthma | |||||
Interventions: | Drug: extrafine HFA-beclomethasone; Drug: HFA-fluticasone | |||||
11 | Completed | Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children | ||||
Condition: | Asthma | |||||
Intervention: | Drug: beclomethasone dipropionate | |||||
12 | Recruiting | Beclomethasone in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant for Hematologic Cancer | ||||
Conditions: | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases | |||||
Interventions: | Drug: beclomethasone dipropionate; Drug: methotrexate; Drug: placebo; Drug: tacrolimus | |||||
13 | Active, not recruiting | Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract | ||||
Condition: | Graft Versus Host Disease | |||||
Intervention: | Drug: beclomethasone dipropionate | |||||
14 | Active, not recruiting | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | ||||
Conditions: | Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Graft Versus Host Disease; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell Tumor | |||||
Intervention: | Drug: beclomethasone dipropionate | |||||
15 | Completed | Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease | ||||
Condition: | Graft Versus Host Disease | |||||
Interventions: | Drug: beclomethasone dipropionate; Drug: methylprednisolone; Drug: prednisone | |||||
16 | Recruiting | Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT) | ||||
Condition: | Asthma | |||||
Intervention: | Drug: Beclomethasone dipropionate | |||||
17 | Completed | Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids | ||||
Condition: | Asthma | |||||
Intervention: | Drug: beclomethasone dipropionate (QVAR) | |||||
18 | Recruiting | Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) | ||||
Condition: | Asthma | |||||
Interventions: | Drug: Tiotropium bromide; Drug: Salmeterol xinofoate; Drug: Beclomethasone dipropionate | |||||
19 | Recruiting | Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-Week Treatment Period of Adult Patients With Uncontrolled Asthma | ||||
Condition: | Bronchial Asthma | |||||
Interventions: | Drug: salbutamol 100 mcg; Drug: BDP/salbutamol HFA pMDI; Drug: BDP/salbutamol CFC pMDI | |||||
20 | Recruiting | Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications | ||||
Conditions: | Asthma; Obesity | |||||
Interventions: | Drug: Beclomethasone dipropionate HFA; Drug: Tiotropium bromide; Drug: Salmeterol xinafoate | |||||
21 | Completed | Study of Inhaled Glucocorticosteroid Administration in Asthma Patients | ||||
Conditions: | Asthma Patients; Well-Controlled | |||||
Interventions: | Drug: Budesonide,hydrofluoroalkane-beclomethasone dipropionate; Drug: Budesonide,hydrofluoroalkane-beclomethasone | |||||
22 | Completed | Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma | ||||
Condition: | Asthma | |||||
Intervention: | Drug: Fixed combination Beclomethasone/formoterol HFA 134a-pMDI | |||||
23 | Completed | Inhaled Beclomethasone to Prevent Chronic Lung Disease | ||||
Conditions: | Bronchopulmonary Dysplasia; Hyaline Membrane Disease; Lung Diseases | |||||
Intervention: | Drug: beclomethasone | |||||
24 | Terminated | Preventing Frequent Sinus Infections in HIV-Infected Patients | ||||
Conditions: | HIV Infections; Sinusitis | |||||
Interventions: | Drug: Pseudoephedrine hydrochloride; Drug: Guaifenesin; Drug: Cefuroxime axetil; Drug: Beclomethasone dipropionate | |||||
25 | Completed | Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients | ||||
Condition: | Asthma | |||||
Intervention: | Drug: Beclomethasone dipropionate HFA | |||||
26 | Completed | Linear Growth Study | ||||
Condition: | Asthma | |||||
Interventions: | Drug: MK0476, montelukast sodium / Duration of Treatment : 56 Weeks; Drug: Comparator : beclomethasone dipropionate / Duration of Treatment : 56 Weeks | |||||
27 | Completed | NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy | ||||
Conditions: | Asthma; Lung Diseases | |||||
Interventions: | Drug: theophylline; Drug: beclomethasone | |||||
28 | Completed | Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) | ||||
Condition: | Seasonal Allergic Rhinitis | |||||
Interventions: | Drug: Beclomethasone dipropionate; Drug: Flunisolide | |||||
29 | Completed | 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis | ||||
Condition: | Rhinitis, Allergic, Seasonal | |||||
Interventions: | Drug: R926112; Drug: Beclomethasone dipropionate | |||||
30 | Completed | Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma | ||||
Conditions: | Respiratory Tract Diseases; Respiratory Hypersensitivity; Asthma | |||||
Intervention: | Drug: ciclesonide | |||||
31 | Completed | Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) | ||||
Condition: | Rhinitis, Allergic, Perennial | |||||
Interventions: | Drug: Ciclesonide; Drug: Placebo | |||||
32 | Active, not recruiting | Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD | ||||
Condition: | Chronic Obstructive Pulmonary Disease | |||||
Intervention: | Drug: CHF 1535, budesonide plus formoterol DPI, Formoterol DPI | |||||
33 | Completed | Non-Invasive Measures of Distal Lung Disease in Asthmatics | ||||
Condition: | Asthma | |||||
Intervention: | Drug: QVAR | |||||
34 | Active, not recruiting | Early Diagnosis of Asthma in Young Children | ||||
Condition: | Asthma | |||||
Intervention: | Drug: beclomethasondipropionate | |||||
35 | Not yet recruiting | Long-Term Oxygen Therapy (LTOT) in Chronic Obstructive Pulmonary Disease (COPD) Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure (CHF) | ||||
Conditions: | Lung Diseases, Obstructive; Chronic Heart Failure; Chronic Hypoxemia | |||||
Interventions: | Other: LTOT (oxygen therapy); Other: Optimal pharmacological therapy of COPD and CHF will follow the international guidelines, | |||||